Hasil Pencarian - C Arrais-Rodrigues

  • Menampilkan 1 - 12 hasil dari 12
Perbaiki Hasil
  1. 1
    CLINICAL CHARACTERISTICS OF A LARGE COHORT OF PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA RECEIVING ANTI-COMPLEMENT TREATMENT IN BRAZIL: A MULTICENTRIC REAL-WORLD EVIDENCE.

    CLINICAL CHARACTERISTICS OF A LARGE COHORT OF PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA RECEIVING ANTI-COMPLEMENT TREATMENT IN BRAZIL: A MULTICENTRIC REAL-WORLD EVIDENCE. oleh CC Justino, P Yamakawa, ARB Fonseca, VC Molla, IB Rabelo, MM Arruda, MS Figueiredo, C Arrais-Rodrigues

    Diterbitkan 2023-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    SÍNDROME MIELODISPLÁSICA SECUNDÁRIA A TERAPIA COM MUTAÇÃO TP53 APÓS TRATAMENTO DE MIELOMA MÚLTIPLO – RELATO DE CASO

    SÍNDROME MIELODISPLÁSICA SECUNDÁRIA A TERAPIA COM MUTAÇÃO TP53 APÓS TRATAMENTO DE MIELOMA MÚLTIPLO – RELATO DE CASO oleh CFM Ferreira, BA Souza, LS Abreu, RAF Machado, EL Rosa, PHA Moraes, VC Molla, RS Szor, CD Liz, C Arrais-Rodrigues

    Diterbitkan 2024-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    ALENTUZUMABE ASSOCIADO A CICLOSPORINA E ELTROMBOPAGUE EM PRIMEIRA LINHA PARA ANEMIA APLÁSICA MUITO GRAVE (AAMG): RELATO DE CASO

    ALENTUZUMABE ASSOCIADO A CICLOSPORINA E ELTROMBOPAGUE EM PRIMEIRA LINHA PARA ANEMIA APLÁSICA MUITO GRAVE (AAMG): RELATO DE CASO oleh RAF Machado, ML Puls, BA Souza, CFM Ferreira, EL Rosa, CD Liz, PHA Moraes, RS Szor, VC Molla, C Arrais-Rodrigues

    Diterbitkan 2024-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    TRANSPLANTE DE CORDÃO UMBILICAL EM ADULTOS EM SERVIÇO PÚBLICO UNIVERSITÁRIO NOS ÚLTIMOS 5 ANOS

    TRANSPLANTE DE CORDÃO UMBILICAL EM ADULTOS EM SERVIÇO PÚBLICO UNIVERSITÁRIO NOS ÚLTIMOS 5 ANOS oleh AG Guerra, GMC Silva, MM Almeida, CC Justino, PHA Moraes, EL Rosa, FDS Azevedo, AMRF Hial, VC Molla, C Arrais-Rodrigues

    Diterbitkan 2024-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    CLADRIBINA SUBCUTÂNEA É OPÇÃO EFICAZ E PRÁTICA NO TRATAMENTO DA TRICOLEUCEMIA: EXPERIÊNCIA DE TRÊS CENTROS BRASILEIROS

    CLADRIBINA SUBCUTÂNEA É OPÇÃO EFICAZ E PRÁTICA NO TRATAMENTO DA TRICOLEUCEMIA: EXPERIÊNCIA DE TRÊS CENTROS BRASILEIROS oleh AP Tavares, FM Marques, MC Seiwald, ACK Vieira, L Perobelli, PA Fernandes, V Pfister, VC Molla, MV Gonçalves, C Arrais-Rodrigues

    Diterbitkan 2024-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    OUTCOMES OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) ACCORDING TO THE REASONS FOR INITIATION OF FIRST-LINE TREATMENT: A RETROSPECTIVE ANALYSIS OF THE BRAZILIAN REGISTRY OF CLL

    OUTCOMES OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) ACCORDING TO THE REASONS FOR INITIATION OF FIRST-LINE TREATMENT: A RETROSPECTIVE ANALYSIS OF THE BRAZILIAN REGISTRY OF... oleh FM Marques, V Pfister, LLM Perobelli, R Santucci, V Buccheri, TB Soares, A Azevedo, MV Gonçalves, CS Chiattone, C Arrais-Rodrigues

    Diterbitkan 2021-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    ANALYSIS OF CLINICAL OUTCOMES OF THE CONSERVATIVE APPROACH IN TREATMENT INDICATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA: INSIGHTS FROM THE BRAZILIAN REGISTRY OF CLL

    ANALYSIS OF CLINICAL OUTCOMES OF THE CONSERVATIVE APPROACH IN TREATMENT INDICATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA: INSIGHTS FROM THE BRAZILIAN REGISTRY OF CLL oleh FM Marques, V Pfister, LLM Perobelli, V Buccheri, M Yamamoto, R Santucci, SC Fortier, CS Chiattone, MV Gonçalves, C Arrais-Rodrigues

    Diterbitkan 2024-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    SEGUNDO TRANSPLANTE ALOGÊNICO EM PACIENTE COM LEUCEMIA LINFOBLÁSTICA AGUDA RECAÍDA E APÓS TERAPIA COM CÉLULAS CAR-T

    SEGUNDO TRANSPLANTE ALOGÊNICO EM PACIENTE COM LEUCEMIA LINFOBLÁSTICA AGUDA RECAÍDA E APÓS TERAPIA COM CÉLULAS CAR-T oleh AG Guerra, GMC Silva, MM Almeida, CC Justino, PHA Moraes, EL Rosa, FDS Azevedo, AMRF Hial, VC Molla, C Arrais-Rodrigues

    Diterbitkan 2024-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    COMPARISON OF CLINICAL AND LABORATORY FEATURES, DRUG AVAILABILITY, AND OUTCOMES OF CLL PATIENTS TREATED IN PUBLIC OR IN PRIVATE HOSPITALS IN BRAZIL: A RETROSPECTIVE ANALYSIS OF THE BRAZILIAN REGISTRY OF CLL

    COMPARISON OF CLINICAL AND LABORATORY FEATURES, DRUG AVAILABILITY, AND OUTCOMES OF CLL PATIENTS TREATED IN PUBLIC OR IN PRIVATE HOSPITALS IN BRAZIL: A RETROSPECTIVE ANALYSIS OF THE... oleh V. Pfister, F.M. Marques, R. Santucci, V. Buccheri, A. Azevedo, T.M.B. Silveira, L. Fogliato, L. Perobelli, C.S. Chiattone, C. Arrais-Rodrigues

    Diterbitkan 2020-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    FAVORABLE OUTCOME IN CLL PATIENTS NOT TREATED DESPITE PRESENTING IWCLL CRITERIA: A RETROSPECTIVE ANALYSIS OF THE BRAZILIAN CLL GROUP

    FAVORABLE OUTCOME IN CLL PATIENTS NOT TREATED DESPITE PRESENTING IWCLL CRITERIA: A RETROSPECTIVE ANALYSIS OF THE BRAZILIAN CLL GROUP oleh F.M. Marques, V. Pfister, R. Santucci, V.C. Molla, Y. Novis, T.M.B. Silveira, M.V. Gonçalves, V. Buccheri, C.S. Chiattone, C. Arrais-Rodrigues

    Diterbitkan 2020-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  11. 11
    REAL-WORLD ANALYSIS OF PATIENTS WITH CLL TREATED WITH IBRUTINIB: A RETROSPECTIVE ANALYSIS OF THE BRAZILIAN REGISTRY OF CLL

    REAL-WORLD ANALYSIS OF PATIENTS WITH CLL TREATED WITH IBRUTINIB: A RETROSPECTIVE ANALYSIS OF THE BRAZILIAN REGISTRY OF CLL oleh V Pfister, FM Marques, R Santucci, V Buccheri, G Ribeiro, VLP Figueiredo, N Hamerschlak, A Costa, T Silveira, A Scheliga, L Perobelli, CS Chiattone, C Arrais-Rodrigues

    Diterbitkan 2024-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  12. 12
    OUTPATIENT SUBCUTANEOUS ALEMTUZUMAB IS FEASIBLE AND SAFE FOR APLASTIC ANEMIA AND ASSOCIATED WITH HIGH RESPONSE RATES

    OUTPATIENT SUBCUTANEOUS ALEMTUZUMAB IS FEASIBLE AND SAFE FOR APLASTIC ANEMIA AND ASSOCIATED WITH HIGH RESPONSE RATES oleh AR Fonseca, CC Justino, VC Molla, PE Yamakawa, IB Rabelo, A Hill, L Arnold, R Kelly, M Griffin, T Munir, E Velloso, T Dalessandro, AM Risitano, P Scheinberg, A Kulasekararaj, C Arrais-Rodrigues

    Diterbitkan 2023-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: